Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRBR BellRing Brands	$66.21 -2.8%	$73.85	$48.06 ▼ $80.67	$8.49B	0.85	1.13 million shs	1.09 million shs
NVO Novo Nordisk A/S	$75.76 +1.3%	$84.15	$73.80 ▼ $148.15	$339.98B	0.42	5.36 million shs	8.22 million shs
PFE Pfizer	$25.60 -0.4%	$26.26	$24.48 ▼ $31.54	$145.08B	0.61	40.06 million shs	36.67 million shs
SMPL Simply Good Foods	$34.27 -2.2%	$36.78	$30.00 ▼ $40.53	$3.46B	0.65	903,942 shs	789,632 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRBR BellRing Brands	-2.65%	-2.97%	-13.16%	-15.13%	+9.40%
NVO Novo Nordisk A/S	+1.36%	-13.86%	-9.57%	-29.17%	-43.24%
PFE Pfizer	-0.49%	-2.31%	+0.26%	+0.07%	-9.24%
SMPL Simply Good Foods	-2.23%	-4.06%	-10.08%	-13.61%	+0.65%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BRBR BellRing Brands	3.3044 of 5 stars	3.4	3.0	0.0	0.0	3.3	2.5	1.3
NVO Novo Nordisk A/S	4.7629 of 5 stars	4.4	4.0	1.7	0.0	3.0	0.0	4.4
PFE Pfizer	4.9719 of 5 stars	3.3	3.0	4.2	4.2	2.8	3.3	3.1
SMPL Simply Good Foods	2.6077 of 5 stars	2.3	3.0	1.7	0.0	3.1	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BRBR BellRing Brands	2.79	Moderate Buy	$78.79	19.00% Upside
NVO Novo Nordisk A/S	2.80	Moderate Buy	$145.25	91.72% Upside
PFE Pfizer	2.59	Moderate Buy	$31.92	24.70% Upside
SMPL Simply Good Foods	2.67	Moderate Buy	$40.22	17.37% Upside

Current Analyst Ratings Breakdown

Latest SMPL, BRBR, NVO, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/13/2025	NVO Novo Nordisk A/S	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
3/12/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
3/10/2025	PFE Pfizer	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/3/2025	NVO Novo Nordisk A/S	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
2/12/2025	NVO Novo Nordisk A/S	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight
2/10/2025	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$33.00 ➝ $33.00
2/6/2025	BRBR BellRing Brands	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$80.00 ➝ $85.00
2/4/2025	BRBR BellRing Brands	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$79.00 ➝ $85.00
2/4/2025	BRBR BellRing Brands	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$75.00 ➝ $75.00
1/29/2025	BRBR BellRing Brands	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$83.00 ➝ $90.00
1/28/2025	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$30.00 ➝ $29.00

(Data available from 3/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BRBR BellRing Brands	$2.10B	4.05	$2.02 per share	32.71	($1.14) per share	-58.08
NVO Novo Nordisk A/S	$290.40B	1.17	$3.51 per share	21.57	$4.64 per share	16.33
PFE Pfizer	$63.63B	2.28	$4.01 per share	6.38	$15.81 per share	1.62
SMPL Simply Good Foods	$1.36B	2.54	$1.87 per share	18.30	$17.25 per share	1.99

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BRBR BellRing Brands	$246.50M	$2.13	31.08	26.07	2.24	13.32%	-130.14%	33.35%	5/5/2025 (Estimated)
NVO Novo Nordisk A/S	$14.64B	$3.29	23.03	16.26	0.90	34.81%	84.68%	26.29%	5/1/2025 (Estimated)
PFE Pfizer	$8.03B	$1.41	18.16	8.45	0.64	12.62%	19.47%	8.09%	4/29/2025 (Estimated)
SMPL Simply Good Foods	$139.31M	$1.41	24.31	17.22	3.23	10.40%	10.25%	7.63%	4/3/2025 (Estimated)

Latest SMPL, BRBR, NVO, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/3/2025	N/A	SMPL Simply Good Foods	$0.39	N/A	N/A	N/A	$354.50 million	N/A
2/5/2025	Q4 2024	NVO Novo Nordisk A/S	$0.88	$0.91	+$0.03	$0.91	N/A	N/A
2/4/2025	Q4 2024	PFE Pfizer	$0.48	$0.63	+$0.15	$0.07	$17.26 billion	$17.76 billion
2/3/2025	Q1 2025	BRBR BellRing Brands	$0.47	$0.58	+$0.11	$0.59	N/A	N/A
1/8/2025	Q1 2025	SMPL Simply Good Foods	$0.43	$0.49	+$0.06	$0.38	$347.32 million	$341.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BRBR BellRing Brands	N/A	N/A	N/A	N/A	N/A
NVO Novo Nordisk A/S	$1.57	2.07%	+25.26%	47.72%	N/A
PFE Pfizer	$1.72	6.72%	+2.50%	121.99%	16 Years
SMPL Simply Good Foods	$0.36	1.05%	N/A	25.53%	N/A

Latest SMPL, BRBR, NVO, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/5/2025	NVO Novo Nordisk A/S	semi-annual	$0.7874	1.2%	3/31/2025	3/31/2025	4/8/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BRBR BellRing Brands	N/A	3.35	1.55
NVO Novo Nordisk A/S	0.62	0.74	0.55
PFE Pfizer	0.63	1.00	0.73
SMPL Simply Good Foods	0.20	4.23	2.75

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BRBR BellRing Brands	94.97%
NVO Novo Nordisk A/S	11.54%
PFE Pfizer	68.36%
SMPL Simply Good Foods	88.45%

Insider Ownership

Company	Insider Ownership
BRBR BellRing Brands	1.07%
NVO Novo Nordisk A/S	0.07%
PFE Pfizer	0.06%
SMPL Simply Good Foods	9.35%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BRBR BellRing Brands	380	128.28 million	126.91 million	Optionable
NVO Novo Nordisk A/S	77,349	4.49 billion	4.48 billion	Optionable
PFE Pfizer	88,000	5.67 billion	5.66 billion	Optionable
SMPL Simply Good Foods	260	101.03 million	91.59 million	Optionable

SMPL, BRBR, NVO, and PFE Headlines

Recent News About These Companies

Wealthfront Advisers LLC Invests $7.88 Million in The Simply Good Foods Company (NASDAQ:SMPL)

March 13 at 4:34 AM | marketbeat.com

AlphaQuest LLC Lowers Stock Holdings in The Simply Good Foods Company (NASDAQ:SMPL)

March 12 at 4:39 AM | marketbeat.com

Candriam S.C.A. Sells 10,741 Shares of The Simply Good Foods Company (NASDAQ:SMPL)

March 11 at 4:02 AM | marketbeat.com

Quest Nutrition Delivers Category Leading Protein with the Launch of Quest™ Protein Milkshakes

March 10, 2025 | prnewswire.com

Victory Capital Management Inc. Trims Stake in The Simply Good Foods Company (NASDAQ:SMPL)

March 9, 2025 | marketbeat.com

Mutual of America Capital Management LLC Reduces Stake in The Simply Good Foods Company (NASDAQ:SMPL)

March 5, 2025 | marketbeat.com

Sanctuary Advisors LLC Purchases New Position in The Simply Good Foods Company (NASDAQ:SMPL)

March 4, 2025 | marketbeat.com

There's Been No Shortage Of Growth Recently For Simply Good Foods' (NASDAQ:SMPL) Returns On Capital

February 27, 2025 | finance.yahoo.com

Simply Good Foods: Becoming A Meaningful Player In Indulgent Good-For-You Snacking

February 27, 2025 | seekingalpha.com

Edge Capital Group LLC Buys New Stake in The Simply Good Foods Company (NASDAQ:SMPL)

February 25, 2025 | marketbeat.com

The Simply Good Foods Company (NASDAQ:SMPL) Receives Consensus Recommendation of "Moderate Buy" from Analysts

February 25, 2025 | marketbeat.com

30,563 Shares in The Simply Good Foods Company (NASDAQ:SMPL) Acquired by South Dakota Investment Council

February 24, 2025 | marketbeat.com

Principal Financial Group Inc. Sells 44,885 Shares of The Simply Good Foods Company (NASDAQ:SMPL)

February 22, 2025 | marketbeat.com

State of New Jersey Common Pension Fund D Sells 7,332 Shares of The Simply Good Foods Company (NASDAQ:SMPL)

February 22, 2025 | marketbeat.com

Handelsbanken Fonder AB Boosts Holdings in The Simply Good Foods Company (NASDAQ:SMPL)

February 21, 2025 | marketbeat.com

New York State Teachers Retirement System Sells 8,936 Shares of The Simply Good Foods Company (NASDAQ:SMPL)

February 21, 2025 | marketbeat.com

Congress Asset Management Co. Has $12.23 Million Stock Position in The Simply Good Foods Company (NASDAQ:SMPL)

February 17, 2025 | marketbeat.com

The Simply Good Foods Company (NASDAQ:SMPL) Among the Best Chocolate Stocks to Buy According to Hedge Funds?

February 12, 2025 | msn.com

The Simply Good Foods Company's (NASDAQ:SMPL) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

January 31, 2025 | finance.yahoo.com

Leadership Transition and Strategic Opportunity at Simply Good Foods: Buy Rating Affirmed

January 30, 2025 | markets.businessinsider.com

Simply Good Foods CFO Shaun Mara to retire, Christopher Bealer to succeed

January 29, 2025 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings
Warren Buffett Swaps VOO for This Reliable Dividend Stock
By Sarah Horvath | March 7, 2025
View Warren Buffett Swaps VOO for This Reliable Dividend Stock
NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
By Gabriel Osorio-Mazilli | February 14, 2025
View NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
By Leo Miller | February 17, 2025
View Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
By Jea Yu | March 10, 2025
View Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

SMPL, BRBR, NVO, and PFE Company Descriptions

BellRing Brands NYSE:BRBR

$66.21 -1.89 (-2.78%)

Closing price 03/13/2025 03:59 PM Eastern

Extended Trading

$66.25 +0.04 (+0.06%)

As of 03/13/2025 04:19 PM Eastern

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands. It distributes its products through club, food, drug, mass, eCommerce, specialty, and convenience channels. BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

Novo Nordisk A/S NYSE:NVO

$75.76 +0.97 (+1.30%)

Closing price 03/13/2025 03:59 PM Eastern

Extended Trading

$76.28 +0.52 (+0.69%)

As of 03/13/2025 07:59 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Pfizer NYSE:PFE

$25.60 -0.11 (-0.43%)

Closing price 03/13/2025 03:59 PM Eastern

Extended Trading

$25.64 +0.04 (+0.14%)

As of 03/13/2025 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Simply Good Foods NASDAQ:SMPL

$34.27 -0.78 (-2.23%)

Closing price 03/13/2025 04:00 PM Eastern

Extended Trading

$34.15 -0.12 (-0.35%)

As of 03/13/2025 05:50 PM Eastern

The Simply Good Foods Company operates as a consumer-packaged food and beverage company in North America and internationally. The company develops, markets, and sells snacks and meal replacements. It offers protein bars, ready-to-drink shakes, sweet and salty snacks, cookies, protein chips, and recipes under the Atkins and Quest brand names. The company also provides confectionery products, such as full-size and mini peanut butter cups, and fudgey brownie and gooey caramel candy bites, chocolatey coated peanut candies, and coconutty caramel candy bars under Atkins Endulge brand name.It distributes its products to various retail channels, such as mass merchandise, grocery and drug channels, club stores, convenience stores, gas stations, and other channels. The company also sells its products through e-commerce channels, including questnutrition.com, atkins.com, amazon.com and others. The Simply Good Foods Company was founded in 2017 and is headquartered in Denver, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time